Related Experiment Video
Updated: Jun 4, 2026
04:50
An Acupoint Catgut-embedding Therapy for Treating Obesity
Published on: April 4, 2025
[Options of adiposity treatment]
1Else Kröner-Fresenius-Zentrum für Ernährungsmedizin, Klinikum Rechts der Isar, Technische Universität München. hans.hauner@lrz.tum.de
Der Internist
|March 4, 2011
Summary
Obesity is a major healthcare challenge linked to increased disease and mortality. Effective management requires personalized lifestyle changes, medical interventions, and strong patient engagement for long-term success.
Area of Science:
- Public Health
- Metabolic Disorders
- Clinical Medicine
Context:
- Obesity's high prevalence presents a significant burden on healthcare systems.
- Expanded body fat is associated with increased morbidity and mortality.
- A wide range of evidence-based treatments exist, requiring individual tailoring.
Purpose:
- To outline current evidence-based treatment options for obesity.
- To emphasize the importance of lifestyle modification and personalized care.
- To highlight the need for societal efforts in primary obesity prevention.
Summary:
- Lifestyle changes, including reduced calorie intake and increased physical activity, form the basis of obesity treatment.
- Interventions encompass very low-calorie diets, pharmacotherapy, behavioral therapy, and bariatric surgery for severe cases.
- Long-term success hinges on patient motivation, self-management, and continuous healthcare support.
Impact:
- Effective obesity management can reduce disease burden and improve patient outcomes.
- Personalized treatment strategies are crucial for successful weight reduction.
- Societal investment in primary prevention is essential to combat the growing obesity epidemic.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:02Hypodermis
The hypodermis (the subcutaneous layer or superficial fascia) is present directly below the dermis. It connects the skin to the underlying fascia (fibrous tissue) of the bones and muscles. It is not strictly a part of the skin, although the border between the hypodermis and dermis can be difficult to distinguish. The hypodermis consists of well-vascularized, loose, areolar connective tissue and adipose tissue, which functions as a mode of fat storage and provides insulation and cushioning for...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...